This list is based on the watchlists of people on Stock Events who follow 2SE.MU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Show more...
FAQ
What is Sequana medical NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sequana medical NV stocks are traded under the ticker 2SE.MU.
When is the next Sequana medical NV earnings date?▼
Sequana medical NV is going to release the next earnings report on August 27, 2026.
What were Sequana medical NV earnings last quarter?▼
2SE.MU earnings for the last quarter are -0.35 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Sequana medical NV have?▼
As of April 12, 2026, the company has 48 employees.
In which sector is Sequana medical NV located?▼
Sequana medical NV operates in the Health & Wellness sector.
When did Sequana medical NV complete a stock split?▼
Sequana medical NV has not had any recent stock splits.
Where is Sequana medical NV headquartered?▼
Sequana medical NV is headquartered in Gent, Germany.